how many people use semaglutide Ozempic Statistics: GLP-1 Weight Loss Medication Data US Population Eligibility and Estimated

461 CITED2 also regulates p53 activity to promote AML, and therefore it can be a potential target for AML therapy

It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists , which were originally developed for type 2 diabetes management

Other studied compartments were eutopic endometrium (93 articles, 24%), peritoneum and peritoneal fluid (74 articles, 19,1%), ovary (mainly follicular fluid or cumulus cells

Front Nutr [Internet] Front Media SA

MedRxiv The Preprint Server for Health Services

In January 2026, an IGD ShopperVista report found that 5.2% of respondents say they have personally used weight loss drugs, an increase of 1% from September 2025